- Home
- RGEN vs ZION Comparison
RGEN vs ZION Comparison
Compare RGEN & ZION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RGEN | ZION |
|---|---|---|
| Founded | 1981 | 1873 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 7.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RGEN | ZION |
|---|---|---|
| Price | $164.88 | $59.55 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 19 |
| Target Price | ★ $174.90 | $60.74 |
| AVG Volume (30 Days) | 663.3K | ★ 1.5M |
| Earning Date | 10-28-2025 | 01-20-2026 |
| Dividend Yield | N/A | ★ 3.04% |
| EPS Growth | N/A | ★ 27.47 |
| EPS | 0.03 | ★ 5.59 |
| Revenue | $707,890,000.00 | ★ $3,207,000,000.00 |
| Revenue This Year | $17.84 | $12.03 |
| Revenue Next Year | $12.44 | $4.35 |
| P/E Ratio | $6,537.77 | ★ $10.60 |
| Revenue Growth | ★ 11.74 | 6.54 |
| 52 Week Low | $102.97 | $39.32 |
| 52 Week High | $182.52 | $60.77 |
Technical Indicators
Market Signals| Indicator | RGEN | ZION |
|---|---|---|
| Relative Strength Index (RSI) | 56.56 | 68.83 |
| Support Level | $156.01 | $58.62 |
| Resistance Level | $167.74 | $60.77 |
| Average True Range (ATR) | 4.38 | 1.29 |
| MACD | -0.10 | 0.11 |
| Stochastic Oscillator | 75.62 | 77.70 |
Price Performance
Historical ComparisonAbout RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
About ZION Zions Bancorporation N.A.
Zions Bancorporation is a regional US bank with core operations that span 11 states. The bank is headquartered in Salt Lake City and does business primarily in the Western and Southwestern United States. Zions focuses primarily on providing banking services to small and midsize businesses, with the bulk of its loans focused on commercial and commercial real estate lending.